Fucoidan Protects against Doxorubicin-Induced Cardiotoxicity by Reducing Oxidative Stress and Preventing Mitochondrial Function Injury

Doxorubicin (DOXO) is a potent chemotherapeutic drug widely used to treat various cancers. However, its clinical application is limited due to serious adverse effects on dose-dependent cardiotoxicity. Although the underlying mechanism has not been fully clarified, DOXO-induced cardiotoxicity has bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Yuting, Jin, Dekui, Qi, Jingyi, Wang, Xuan, Zhang, Chengying, An, Peng, Luo, Yongting, Luo, Junjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504360/
https://www.ncbi.nlm.nih.gov/pubmed/36142635
http://dx.doi.org/10.3390/ijms231810685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504360/
https://www.ncbi.nlm.nih.gov/pubmed/36142635
http://dx.doi.org/10.3390/ijms231810685

Ejemplares similares